Profile_bird

Hey there! cci_compliance is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving cci_compliance's tweets.

Already using Twitter
from your phone? Click here.

cci_compliance

  1. Most Recent Featured Column: The SEC Claws Back by Dan Hurson | http://bit.ly/6GPBkE
  2. Will Increasing Proxy Access for Shareholders Lead to Chaos? | http://bit.ly/71dUIH
  3. Corpedia and @ethisphere Form Joint Committee on Business Ethics: http://bit.ly/7qyDco
  4. New FCPA Column by Mike Koehler: A Bribery Scheme Hatched at the “Eggs Benedict Place” | http://bit.ly/7YtcSx
  5. The Interesting FCPA Investigations Regarding Blackwater and Morgan Stanley | http://bit.ly/1zeBig
  6. Critical FCPA and Export Compliance Issues for the Health Care Industry | http://bit.ly/15LcXE
  7. Will Increasing Proxy Access for Shareholders Lead to Chaos? | http://bit.ly/71dUIH
  8. FCPA Roundup: Another Speech, Lighthouses and Buoys, and an FCPA Triangle | http://bit.ly/1G5L5h
  9. Top Five Compliance Risks Facing Life Sciences Companies | http://bit.ly/1mp3zz
  10. Some recent CCI posts forthcoming, in cased you missed them...
  11. New Feature Article: The SEC Claws Back - The case for strict enforcement of Sarbanes-Oxley Section 304 | http://bit.ly/6GPBkE
  12. @dancathy thanks for the RT on the CCI post. Your videos at EBLCenter.org are terrific. http://bit.ly/r1YlM
  13. New CCI Featured Article from Partners at @ernst_and_young: Top 5 Compliance Risks Facing Life Sciences Companies | http://bit.ly/1mp3zz
  14. FCPA Roundup from CCI Featured FCPA Columnist Mike Koehler: http://bit.ly/1G5L5h
  15. New CCI Featured Article: Critical FCPA and Export Compliance Issues for the Health Care Industry | http://bit.ly/15LcXE
  16. CCI Series on Ethical Leadership: Chick-Fil-A President @dancathy on Importance of Personal Ethics http://bit.ly/r1YlM
  17. New Featured Article: Economic Downturn an Opportunity for CCOs | http://bit.ly/VFhBD
  18. New Featured Article: Internal Fraud Investigations: The Risk and Reward of Third Party Involvement | http://bit.ly/15f1L
  19. The Four Greatest Risks of a Fraud or False Claims Act Suit against Pharmaceutical Companies http://bit.ly/3harEx
  20. Josh Blaisdell Named VP Corporate Compliance at CHShttp://bit.ly/4mydbw